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Serum vitamin A concentration 
is elevated in idiopathic 
intracranial hypertension 
D,M. Jacobson, MD; R. Berg, MS; M. Wall, MD; K.B. Digre, MD; J.J. Corbett, MD; and R.D, Ellefson, PhD 
Article abstract-Objective: The primary purpose was to investigate whether serum vitamin A concentration is associ-. 
ated with idiopathic intracranial hypertension (IIHl. The secondary aim was to obtain pilot data regarding the amount of 
vitamin A ingested by patients and controls. Background: Vitamin A is an attractive candidate mediator of IIR as many of 
the symptoms and signs of hypervitaminosis A mimic those of HR. Methods: We prospectively determined serum retinol 
and retinyl ester concentration in 16 women with IIR and 70 healthy young women. Using a survey instrument, we also 
determined the average daily vitamin A ingestion in a convenience sample of patients and controls. Results: Serum retinol 
concentration was significantly higher in the patient group (median 752 uglL) compared with the control group (median 
530 ugIL), even after adjusting for age and body mass index (p < 0.001). Retinyl ester concentration, however, was similar 
in the patient (median 48 ugIL) and control (median 41 uglL) groups (p = 0.32). There was no significant correlation 
between serum retinol concentration and body mass index in the patients (r = 0.16) or controls (r -0.02). Finally, there 
was no significant difference in the amounts of vitamin A ingested by the patients or controls, although the small number 
of subjects in both groups reduced the power of this conclusion, Conclusions: Elevated serum retinol concentration is 
associated with IIR. Obesity, by itself, does not explain these higher levels. Patients may ingest an abnormally large 
amount of vitamin A, metabolize it abnormally, or be unusually sensitive to its effects. Alternatively, elevated level of 
serum retinol may reflect an epiphenomenon of another variable we did not measure or a nonspecific effect of elevated 
retinol binding capacity. Key words: Idiopathic intracranial hypertension-Vitamin A-Retinol-Obesity. 
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Idiopathic intracranial hypertension (IIH), also 
known as pseudotumor cerebri or benign intracra-
nial hypertension, usually occurs in otherwise 
healthy overweight women of childbearing age.1.2 
These attributes suggest that a hormonal or meta-
bolic agent of women who are overweight and young 
is important in the pathogenesis of this condition. 
Whereas many exogenous agents and endogenous 
metabolic disturbances have been implicated in caus-
ing increased CSF pressure, those factors have been 
reported in single case reports or small uncontrolled 
series that often involved patients who failed to ful-
fill a modern case definition of IIH.3 Moreover, 
no single disease or toxin has been identified as sig-
nificantly associated with IIH using a case-control 
analysis.:l ,4 
Vitamin A is an attractive candidate mediator of 
IIH. Many reports confirm vitamin A intoxication 
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produces symptoms and signs indistinguishable 
from IIH.5.6 Intoxication has resulted from exces-
sive ingestion of vitamin A supplements,7'11 foods 
rich in vitamin A content,12.13 and therapeutic reti-
noid derivatives. 14.17 Hypervitaminosis A has also 
been implicated in IIH associated with chronic re-
nal failure. IS 
If hypervitaminosis A is indeed important in the 
development of typical IIH, then one could hypothe-
size that either affected patients ingest excessive 
amounts of this nutrient or that their metabolism of 
it is somehow altered. The primary purpose of our 
investigation was to investigate whether serum vita-
min A concentration is associated with IIH. A sec-
ondary aim was to obtain pilot information to 
determine if there are differences in the amount of 
dietary vitamin A ingested by patients with IIH and 
control subjects. 
Methods. This was a prospective cross-sectional survey 
conducted in three phases. The first phase of the investiga-
tion was to establish a reference range for serum vitamin 
A in young women. The next phase of the investigation-
based on sample size estimation derived, in part, from 
results of the first phase-involved prospective recruit-
ment of patients with HH. Finally, a convenience sample 
of patients and controls was investigated using a survey 
instrument to obtain pilot data in order to compare the 
amounts of dietary vitamin A ingestion in both groups. 
The procedures outlined in the following were reviewed 
and approved by the Institutional Review Boards of the 
participating institutions. All participating subjects and 
patients provided written informed consent after the na-
ture of the procedures had been explained to them. 
Control subjects. Control subjects were prospectively 
recruited in order to establish reference values for serum 
vitamin A concentration and to obtain dietary information 
regarding vitamin A ingestion. All of the control subjects 
recruited for vitamin A determination were enrolled by the 
principal investigator (D.M.J,l. We identified potential con-
trol subjects by advertising our interest in periodicals dis-
tributed to employees at our institution and women 
receiving dietary counseling. Interested participants un-
derwent formal screening for entry criteria by trained re-
search study coordinators. Only women between the ages 
of 18 and 45 years were enrolled. Because of the demo-
graphic composition of the referral region of the principal 
investigator's institution, and not by design, only white 
women were enrolled. Potential subjects were excluded 
from enrollment if they had been diagnosed with IIH at 
any time or if they experienced daily headaches, transient 
visual obscurations, diplopia, pulsatile intracranial noises, 
or focal neurologic symptoms. Subjects were not enrolled if 
they were pregnant, had delivered a baby within the last 2 
months, or were breast-feeding. Subjects receiving retinoid 
medication, eating more than one serving of liver per 
week, or receiving more than 5,000 IU or 800 ug retinol 
equivalent daily were excluded from enrollment, as these 
conditions would contribute to hypervitaminosis A. The 
presence of renal disease, liver disease, diabetes, hyperten-
sion, or daily alcohol use also constituted exclusion from 
enrollment as these conditions alter vitamin A metabo-
lism. Finally, a potential subject was excluded if receiving 
more than 200 IU of vitamin D daily or more than 8 mg of 
a-tocopherol equivalents daily, as some pharmaceutical 
preparations of those substances have been observed to 
contain retinol. Subjects who fulfilled all entry criteria 
were paid $10.00 for participating. 
In addition to submitting a blood sample for vitamin A 
determination, each control subject also had her weight (in 
kilograms) and height (in meters) measured by a trained 
research study coordinator. Body mass index (EMn was 
then calculated as weight divided by height squared. 
Initial recruitment efforts occurred without regard to 
targeted BM!. Because we did not know if an association 
existed between serum vitamin A concentration and BMI 
our goal was to enroll subjects who represented a full 
range of BMI values. Following interim analyses during 
the enrollment phase, subjects with certain BM! values 
were more specifically targeted in order to achieve our 
goal. Before recruitment started, we determined that a 
sample size of 84 subjects was required in order to detect a 
correlation between serum vitamin A concentration and 
BMI of 0.3 with 80% power. 
Additional obese white women between the ages of 18 
and 45 years who did not have HH were recruited from the 
outpatient practices of the investigators in order to obtain 
dietary information regarding vitamin A ingestion (see fol-
lowing). Their heights and weights were recorded. Obesity 
was defined as BMI greater than 30. 19 The same entry 
criteria described earlier were applied to these subjects'. 
Patients. To ensure a valid comparison with the con-
trols, cases were prospectively recruited and studied using 
standardized methods. Only white women between the 
ages of 18 and 45 years with IIH characterized by fulfill-
ment of the modified Dandy criteria2 were asked to partic-
ipate. Potential patients were excluded if their symptoms 
had been present for more than 3 months or if they were 
receiving treatment, including diuretic, corticosteroid, or 
supervised weight reduction. The other exclusion criteria 
applied to control subjects were also applied to potential 
patients. We recorded the duration of symptoms, papill-
edema grade using a standardized grading scheme,20 qual-
itative pattern of visual field loss, and opening pressure 
measured at the time of diagnostic lumbar puncture. 
Based on review of control data and retrospective cases, 
we determined that the study required at least 13 patients 
to provide 90% statistical power for the comparison of 
cases and controls (two-sided test with a 0.05). The 
study was conservatively planned to allow up to 20 pa-
tients to be enrolled. Reevaluation of sample size assump-
tions after enrolling 16 patients showed power exceeding 
90% and enrollment was terminated. 
Vitamin A assays. Serum samples from 20-mL speci-
mens of clotted blood were frozen promptly after separa-
tion of the clots, protected from light exposure, and sent 
packed with dry ice to the analytic laboratory m.D.EJ. 
Two or more samples with masked labeling were separated 
from each specimen for evaluation of analytic precision, 
verification of the sensitivity of the analyses, and second 
(duplicate) analysis on a second day. Each specimen sam-
ple was stored in a-70°C freezer between analyses. 
The fat-soluble vitamins were extracted from the serum 
samples with isopropyl alcohol and heptane; control sera 
and a saline blank were treated in the same way. The 
retinol and retinyl esters were quantified by ultraviolet 
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absorbance using a high-pressure liquid chromatography 
(HPLC) system. The HPLC system was calibrated with 
purified retinol and retinyl palmitate (Sigma Chemical 
Company, St. Louis, MO) dissolved in heptane. Because 
beta-carotene co-chromatographed with retinyl esters, the 
system was also calibrated with beta-carotene. The retinol 
and retinyl esters were quantified according to absor-
bances at 325 nm. Beta-carotene absorbs sufficiently at 
325 nm to cause significant error in the quantitation of 
retinyl esters. Therefore, a correction for the beta-carotene 
absorbance at 325 nm was determined by measuring the 
beta-carotene absorbance at 325 nm for each specimen, 
and the beta-carotene absorbance at 450 nm; the ratio of 
absorbances at 450 nm and 325 nm as observed with the 
beta-carotene standard were used in the calculation of the 
retinyl ester values. 
The HPLC system included a spectrophotometric detec-
tor set to monitor the column effluent continuously at 325 
nm and 450 nm. The chromatographic column (micro-
Bondapak, Waters Corporation, Miltbrd, MA) was packed 
with 5-um particles coated with octadecyl units, and the 
system was operated isocratically with a mixture of aceto-
nitrile 75% and methanol 25%. 
Vitamin A questionnaire. We searched Nutritionist IV 
version 1.0 (N-Squared Computing, Salem, OR), a 
nutrition-specific computerized database, to identify the 
vitamin A content of food items. We then selected specific 
food items from each of the major categories of food groups 
for inclusion in our survey instrument based on high con-
centration of vitamin A and high frequency of expected 
use. We assigned a reference portion for each of the 36 
foods included in our survey instrument. Subjects were 
asked to indicate their eating frequency of each of the 
items by selecting never or indicating the number of times 
per day, week, or month they ate the reference portion. 
Pictures of the food and reference portions were available 
for many of the survey items to assist subjects in defining 
their eating frequencies. For each item, the retinol equiva-
lent per day was calculated by multiplying the retinol 
equivalent per reference portion by the eating frequency. 
The total retinol equivalents per day was then calculated 
by summing the total retinol equivalents per day of each of 
the food items. 
Statistical analyses. Assays for retinol and retinyl es-
ters for individual serum samples were replicated, and 
sample medians over the replicates were used for analysis. 
The primary statistical analyses were based on nonpara-
metric procedures owing to the non-normal (skewed) dis-
tributions of the response variables. Comparisons of 
patient and control results were based on the Wilcoxon 
rank-sum procedure, and associations between variables 
were assessed with Spearman rank correlations. The com-
parisons of patient and control results for retinol and reti-
nyl ester were adjusted for age and BMI in a general linear 
model (i.e., analysis of covariance) after log transformation 
of the ester values. 
Results. The table summarizes the main results of our 
comparisons between patients with IIH and control sub-
jects. We enrolled 70 control subjects, ranging in age from 
18 to 45 years and with a median (mean) age of 36 (34) 
years. Their BMI ranged from 17 to 53, with a median 
(mean) value of 27 (31). The serum retinol levels of the 
controls ranged from 293 to 990 ug/L with a median 
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Table Comparison of major variables in patients with idiopathic 
intracranial hypertension and control subjects 
Variable 
-------... -~~~ .. 
Age (y), range 
Median, mean (p = 0.003) 
Body mass index (kgJM2), range 
Median, mean (p = 0.047) 
Serum retinol (ug/L), range 
Median, mean (p < 0.001) 
Serum retinyl esters (uglL), range 
Median, mean (p = 0.32) 
Vitamin A ingestion (retinol 
equivalents/d)* 
Median, mean (p = 0.95) 2,308,2,785 1,542,3,816 
--------_ .. _ .. _ .. 
* Data from 13 patients and 10 controls contributed to the vita-
min A ingestion comparison. 
(mean) of 530 ug/L (547 ug/L) (figure 1). Their serum reti-
nyl ester levels ranged from 9 to 142 ug/L with a median 
(mean) of 41 ug/L (46 ug/L) (figure 2). 
We also enrolled 16 patients with IIH, ranging in age 
from 18 to 42 years of age and with both'a median and 
mean age of28 years. The duration ofIIH ranged from 1 to 
13 weeks (median 6 weeks). Papilledema in the worse eye 
was grade 1 in 12%, grade 2 in 37%, grade 3 in 25%, grade 
4 in 6%, and grade 5 in 19% of patients. The predominant 
visual field pattern of both eyes in the patients included 
isolated blind spot enlargement in 26 eyes, inferior arcuate 
1200 1200 
•• 
1000 • •• 1000 
• g 800 •• 800 •• ~ •• 
~ ·h •• 
• 
'0 600 :. 600 
:S • • • 
~ 







Figure 1. Scattergram shows individual values of serum 
retinol concentration for controls and patients. The upper 
and lower sides of the rectangle represent the 75th and 
25th percentile values. The horizontal bar within the rect-
angle represents the median value, which differs signifi-
cantly between the two groups. Note that, despite the 
overlap of patient and control values, the majority of pa-






































































Figure 2. Scattergram shows individual values of serum 
retinyl ester concentration for controls and patients. The 
upper and lower sides of the rectangle represent the 75th 
and 25th percentile values. The horizontal bar within the 
rectangle represents the median value, which does not dif-
fer significantly between the two groups. 
loss in 5 eyes, and severe superior and inferior nasal arcu-
ate loss in 1 eye. Opening CSF pressures during diagnostic 
lumbar puncture ranged from 220 to 500 mm CSF, with a 
median (mean) value of 355 mm CSF (361 mm CSF). 
The BMI of patients with IIH ranged from 27 to 68 with 
a median (mean) value of 32 (35), and was somewhat 
greater than the BMI of control subjects (p = 0.047; see 
table). Controls were significantly older than patients (p = 
0.003; see table 1), but the ranges in age were very similar. 
The serum retinol concentrations of patients ranged from 
421 to ll20 ug/L with a median (mean) of 751 ugIL (789 
ug/L). The difference in serum retinol between controls 
and patients was statistically significant (p < 0.001), and 
remained significant after adjusting for age and BMI (p < 
0.001; see figure 1, table). The serum retinyl ester concen-
trations of patients ranged from 8 to 154 ug/L with a 
median (mean) of 48 ug/L (55 ug/LL There was no signifi-
cant difference in retinyl ester levels between controls and 
patients (p = 0.32; see figure 2, table). 
There was no significant correlation between serum ret-
inollevel and age in the control (r -0.19, p 0.11) or 
patient (r = 0.24, P = 0.37) groups. Likewise, there was no 
significant correlation between serum retinol level and 
BMI in either the control (r = -0.02, p = 0.89) or patient 
(r = 0.16, p = 0.54) group. Finally, there was no significant 
correlation between patient serum retinol concentration 
and duration of their symptoms (r -0.06, p 0.82), or 
papilledema grade (r 0.12, p = 0.66) of their more se-
verely affected eye. 
There was no significant difference in amounts of vita-
min A ingestion between the 10 controls (median, 1,542 
retinol equivalents per day) and 13 patients (median, 2,308 
retinol equivalents per day) who completed the nutrition 
survey instrument (p 0.95). However, the small nUlll-
bers of subjects provide relatively little statistical power 
for this comparison. A sample size calculation, using a log 
scale to correct for the skewed distribution, indicated that 
we would need at least 110 individuals per group to pro-
vide a power of 80% in a two-tailed test (p value = 0.05) to 
identify a true difference of 800 retinol equivalents per 
day, if one existed. 
Discussion. We found that serum concentrations 
of vitamin A, in the form of retinol, are significantly 
higher in patients with IIH than in healthy controls. 
There was no association between serum retinol 
level and BMI in the control or patient populations. 
This suggests that obesity, although well docu-
mented as strongly associated with IIH, is not, by 
itself, the patient characteristic responsible for caus-
ing higher levels of vitamin A in affected individuals. 
The pilot data from our dietary survey do not suggest 
that elevated retinol concentrations in patients 
result from abnormally greater ingestion of dietary 
vitamin A. However, this conclusion must be tem-
pered by the fact that the small number of patients 
and controls lowers the statistical power of this 
comparison. 
How might excessive circulating vitamin A pro-
duce increased intracranial pressure? When specifi-
cally bound, circulating retinol and retinyl esters are 
not toxic. Intoxication in humans occurs when the 
capacity for hepatic storage or binding to retinol 
binding protein is exceeded.21,22 At that level of hy-
pervitaminosis A, the proportion of the circulating 
retinyl esters increases. Increased plasma levels of 
retinol and retinyl esters then circulate nonspecifi-
cally bound to lipoproteins. As such, the excessive 
retinol and retinyl esters can interact with cell mem-
branes and produce damage by membranolytic 
surface-active properties. If increased circulating ret-
inol interacted nonspecifically with cellular mem-
branes of the arachnoid granulations to disrupt cell 
membrane integrity, then CSF outflow would be 
impaired.23•25 The elevation of intracranial pressure 
that resulted from this process could then produce 
typical symptoms and signs of IIH in a predisposed 
individual. 
Some reported cases of human hypervitaminosis A 
had elevated circulating retinyl esters that corre-
lated with symptoms of toxicity better than retinol 
concentrations. 9 •12,26.28 Our patients, on the other 
hand, had normal levels of retinyl esters. The mini-
mal level to which serum retinol concentrations were 
elevated in patients with IIH differs markedly from 
the toxic levels reported in patients with hypervita-
minosis A, and probably explains why retinyl ester 
levels were normal in our patient group. 
It is unlikely that the elevated serum retinol con-
centration in patients with IIH was the result of 
reduced hepatic or retinol binding protein binding 
capacity for several reasons. None of our patients 
had malnutrition, liver disease, renal disease, or pro-
teinuria, or was taking medication (e.g., glucocorti-
coid) that can alter metabolism or affect binding 
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capacity of retinol binding protein. The concentration 
of retinyl esters, the vitamin A fraction usually ele-
vated when retinol binding protein capacity is ex-
ceeded, was not significantly differen t between 
patients and controls. This suggests that elevated 
retinol in patients with IIH is an epiphenomenon or 
a nonspecific effect of altered vitamin A metabolism. 
Indeed, Selhorst et al.29 found that the concentration 
of retinol binding protein was abnormally elevated in 
a greater number of patients than controls. 
Despite our positive results, it seems unlikely that 
retinol toxicity, by itself, is directly related to the 
pathogenesis of IIH for several reasons. Many pa-
tients with IIH had serum retinol values that over-
lapped with control values (see figure 1). In many 
patients, the retinol value was below the upper con-
trol limit. Serum retinyl ester levels were not signif-
icantly greater than control values. However, it 
remains possible that mild elevation of serum retinol 
is one factor that contributes to elevated intracranial 
pressure in predisposed women. 
Vitamin A may cause or contribute to the develop-
ment of IIH in several ways: Patients may ingest an 
abnormally large amount of it, metabolize it abnor-
mally, or be unusually sensitive to its effects. Alterna-
tively, elevated level of serum retinol in patients with 
IIH may reflect an epiphenomenon of a variable we did 
not measure or a nonspecific effect of elevated retinol 
binding capacity. Our results provide testable hypothe-
ses for future investigations of these possibilities. 
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